SEARCH Articles Figures Tables 90Y-ibritumomab tiuxetan Cancer treatments ibritumomab Ibritumomab tiuxetan Ibritumomab tiuxetan (Zevalin IDEC Monoclonal antibody therapy Ibritumomab Tiuxetan